Latest News for: lexx

Edit

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking To Replicate Results From First GLP-1 Study Following CRO ...

MENA FN 04 Apr 2025
(MENAFN - Investor Brand Network). Lexaria, a global innovator in drug delivery platforms, recently hired a contract research organization (–CRO–) for its upcoming chronic human study, GLP-1-H24-4 ... .
  • 1
×